Clinical usefulness of bone markers in prostate cancer with bone metastasis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical usefulness of bone markers in prostate cancer with bone metastasis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF UROLOGY
Volume 19, Issue 11, Pages 968-979
Publisher
Wiley
Online
2012-07-19
DOI
10.1111/j.1442-2042.2012.03098.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Denosumab
- (2013) Allan Lipton et al. Current Opinion in Supportive and Palliative Care
- Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis
- (2011) Kouji Izumi et al. BJU INTERNATIONAL
- Dasatinib combined with docetaxel for castration-resistant prostate cancer
- (2011) John C. Araujo et al. CANCER
- Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis
- (2011) Naoto Kamiya et al. International Journal of Clinical Oncology
- Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer
- (2011) Matthew R Smith et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer
- (2011) F. Dayyani et al. JNCI-Journal of the National Cancer Institute
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Once-daily Dasatinib: Expansion of Phase II Study Evaluating Safety and Efficacy of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer
- (2011) Evan Y. Yu et al. UROLOGY
- Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer
- (2010) S. Rajpar et al. ANNALS OF ONCOLOGY
- Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
- (2010) Patrick Garnero et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Application of a Fracture Risk Algorithm to Men Treated With Androgen Deprivation Therapy for Prostate Cancer
- (2010) Philip J. Saylor et al. JOURNAL OF UROLOGY
- Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer
- (2010) Fred Saad et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Implications of Serum Bone Turnover Markers in Prostate Cancer Patients With Bone Metastasis
- (2010) Naoto Kamiya et al. UROLOGY
- Bone-marker levels in patients with prostate cancer: potential correlations with outcomes
- (2010) Fred Saad et al. Current Opinion in Supportive and Palliative Care
- Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2009) E. Y. Yu et al. CLINICAL CANCER RESEARCH
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
- (2008) Allan Lipton et al. CANCER
- Bone markers and their prognostic value in metastatic bone disease: Clinical evidence and future directions
- (2008) Robert Coleman et al. CANCER TREATMENT REVIEWS
- Molecular mechanisms and treatment of bone metastasis
- (2008) Gregory A. Clines et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer
- (2008) Choichiro Ozu et al. INTERNATIONAL JOURNAL OF UROLOGY
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now